Found "Public health policy": 1,085 results
Sort by
Relevance

DNA Blueprint for Fetus Built Using Tests of Parents

For the first time, researchers have determined virtually the entire genome of a fetus using only a blood sample from the pregnant woman and a saliva specimen from the father.The accomplishment heralds an era in which parents might find it easier to know the complete DNA blueprint of a child months

A Geneticist’s Research Turns Personal

HUMAN genome sequencing is already helping researchers find new treatments for illness. Now an unusual case study suggests that the benefits of sequencing may be enhanced in combination with detailed blood tests.The case involves Michael Snyder, a geneticist who was both the lead author and the subj

China detains almost 2,000 in fake drug sweep

(Reuters) – Chinese police have detained almost 2,000 people in a nationwide sweep on fake drugs, seizing more than $180 million worth of counterfeit products and destroying some 1,100 production facilities, the public security ministry said on Sunday.The operation, involving around 18,000 police of

FDA warns Hershey over chocolate syrup labeling

In a warning letter to the company dated February 14, made public on Tuesday, the FDA said the labels on Hershey’s Syrup+Calcium and its Syrup Sugar Free with Vitamin & Mineral Fortification violate federal law.The FDA said the company may not use the terms “plus” and “fortification” on the labe

St. Jude Is Told to Study a Defect in Heart Devices

The Food and Drug Administration ordered St. Jude Medical on Thursday to conduct additional studies on patients implanted with heart-device components that were recalled last year and that have been linked to as many as 20 deaths. It also recommended that patients receive X-rays or other imaging to

Developing policy options for breast cancer screening in Thai women

This study aims to determine the appropriate method for screening breast cancer in Thai women both in terms of effectiveness and cost-effectiveness. The research was divided into four phases: Phase 1 - systematic literature review of risk factors and a clinical prediction score of breast cancer in Thai women, Phase 2 - preparation of a clinical pre

HTA of COVID-19 vaccines in Thailand

To calibrate the Covid M SEIR model to Thailand and to build capacity to use the model to address policy questions in Thailand. This project will address COVID-19 vaccination policy questions, such as frequency and target population for booster doses, as well as development of web-based applications to communicate the results to policymakers and ot

South Korea’s Experience of Reimbursing High-Cost Medicines

Cost-effectiveness and availability of alternative treatment options play a crucial role in the listing of new medicines in South Korea. However, high-cost medicines with no alternative treatment options, particularly those for treating cancer and rare diseases, were not reimbursed under the traditi

What criteria do decision makers in Thailand use to set priorities for vaccine introduction? (2016)

Siriporn Pooripussarakul1, Arthorn Riewpaiboon1* , David Bishai2, Charung Muangchana3 and Sripen Tantivess4 Abstract Background: There is a need to identify rational criteria and set priorities for vaccines. In Thailand, many licensed vaccines are being considering for introduction into the Ex
10 / Page